Lipases and their inhibitors in health and disease
Authors:
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 259, 211-222
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P42ES004705, R01CA172667)
- American Cancer Society Research Scholar Award (RSG-14-242-01-TBE)
- DOD (CDMRP W81XWH-15-1-0050)
- BASF-CARA
- National Institutes of Health (P01ES00049)
- University of California Berkeley
This publication has 144 references indexed in Scilit:
- Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's DiseaseCell Reports, 2012
- Highly Selective Inhibitors of Monoacylglycerol Lipase Bearing a Reactive Group that Is Bioisosteric with Endocannabinoid SubstratesChemistry & Biology, 2012
- Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate CancerChemistry & Biology, 2011
- A Potent and Selective Inhibitor of KIAA1363/AADACL1 that Impairs Prostate Cancer PathogenesisChemistry & Biology, 2011
- Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assayPharmacology Biochemistry and Behavior, 2011
- Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor MechanismsThe Journal of Pain, 2010
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer PathogenesisCell, 2010
- Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid MetabolismChemistry & Biology, 2009
- Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainChemistry & Biology, 2009
- Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxificationToxicology and Applied Pharmacology, 2008